Cargando…
Comment on ‘Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study’
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5808019/ https://www.ncbi.nlm.nih.gov/pubmed/29149108 http://dx.doi.org/10.1038/bjc.2017.342 |
| _version_ | 1783299381969027072 |
|---|---|
| author | Bravo, Isabel |
| author_facet | Bravo, Isabel |
| author_sort | Bravo, Isabel |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5808019 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-58080192019-02-06 Comment on ‘Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study’ Bravo, Isabel Br J Cancer Letter to the Editor Nature Publishing Group 2018-02-06 2017-11-16 /pmc/articles/PMC5808019/ /pubmed/29149108 http://dx.doi.org/10.1038/bjc.2017.342 Text en Copyright © 2018 Cancer Research UK http://creativecommons.org/licenses/by-nc-sa/4.0/ From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ |
| spellingShingle | Letter to the Editor Bravo, Isabel Comment on ‘Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study’ |
| title | Comment on ‘Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study’ |
| title_full | Comment on ‘Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study’ |
| title_fullStr | Comment on ‘Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study’ |
| title_full_unstemmed | Comment on ‘Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study’ |
| title_short | Comment on ‘Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study’ |
| title_sort | comment on ‘efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study’ |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5808019/ https://www.ncbi.nlm.nih.gov/pubmed/29149108 http://dx.doi.org/10.1038/bjc.2017.342 |
| work_keys_str_mv | AT bravoisabel commentonefficacyofstereotacticbodyradiotherapyinoligorecurrentandinoligoprogressiveprostatecancernewevidencefromamulticentricstudy |